Over time, cancer cells often stop responding to the treatment that is keeping the tumor in check. This is called treatment resistance.
Below you will find three articles that address different aspects of treatment resistance. The first article describes research looking into the genetics of cells that become resistant. The goal is to use this information to identify new treatments. Following that are articles about treatment resistance in ER+ breast tumors and the relationship between HER2 mutations and resistance to hormone therapies.
Looking for more information? There’s an entire journal devoted to the topic: Cancer Drug Resistance. You can find it here: CDR Journal.
- National Cancer Institute: Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer
- Medical News Today: Why Do Some Breast Cancers Become Treatment Resistant?
- Green Hill Healthcare Communications: Acquired HER2 Mutations in Metastatic Breast Cancer
Last Modified on August 18, 2020
Tags:HER2Genetics & GenomicsTreatment ResistanceAreas of ResearchResearch News